Clinical review: Impact of statin substitution policies on patient outcomes.
- Published in:
- Annals of Medicine, 2009, v. 41, n. 4, p. 242, doi. 10.1080/07853890902729786
- By:
- Publication type:
- Article
Works by K-Laflamme, Annik
Results: 6
1
2
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIG MS study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 922, doi. 10.1177/1352458520936934
- By:
- Publication type:
- Article
3
Correction to: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMSII Trials.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
4
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials.
- Published in:
- Neurology & Therapy, 2019, v. 8, n. 2, p. 461, doi. 10.1007/s40120-019-0146-z
- By:
- Publication type:
- Article
5
Impaired Basal Sympathetic Tone and α<sub>1</sub>-Adrenergic Responsiveness in Association With the Hypotensive Effect of Melatonin in Spontaneously Hypertensive Rats<sup>*</sup>.
- Published in:
- American Journal of Hypertension, 1998, v. 11, n. 2, p. 219, doi. 10.1016/S0895-7061(97)00401-9
- By:
- Publication type:
- Article
6
Effect of congestive heart failure on clentiazem pharmacokinetics in a dog model.
- Published in:
- Biopharmaceutics & Drug Disposition, 1992, v. 13, n. 7, p. 513, doi. 10.1002/bdd.2510130705
- By:
- Publication type:
- Article